Patient Guide: Open-label Study Comparing Iberdomide, Daratumumab and Dexamethasone (IberDd) Versus Daratumumab, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 259 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT04975997
Status: ACTIVE_NOT_RECRUITING
Condition: Multiple Myeloma, Neoplasms, Plasma Cell
Phase: PHASE3

Find a Study Location Near You

This study is available at 259 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Hot Springs, Arkansas
  • Cerritos, California
  • Fountain Valley, California
  • • And 256 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily